DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Bethesda North Marriott Hotel and Conference Center

2023 年 02 月 06 日 1:00 下午 - 2023 年 02 月 09 日 12:35 上午

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Global Pharmacovigilance and Risk Management Strategies Conference

Stay current with the latest safety regulations from global health authorities and regulatory experts!

Keynote Address: Research Integrity in the Quest for Therapies for Alzheimer’s Disease

Session Chair(s)

Annette S. Williams, MBA, RPh

Annette S. Williams, MBA, RPh

Vice President, Pharmacovigilance

IQVIA, United States

This session will present the history of experimental anti-amyloid therapies for Alzheimer’s disease in the context of recent revelations regarding potential research integrity concerns underlying assumptions of the amyloid cascade hypothesis. This case will illustrate the persistent corruptive influence of research misconduct on the evolution of a field of study. The session will close with a discussion of the responsibilities of co-authors, funders, publishers, and regulatory bodies on maintaining high standards of integrity and strategies to limit the damage from unreliable data sources.

Learning Objective :
  • Recognize risk factors for research misconduct and strategies for mitigating influence of unreliable data sources
  • Formulate approaches to misconduct concerns that mitigate collateral damage while ensuring deep commitment to data integrity
  • Propose strategies to lower the risk of research misconduct and influence of inaccurate data sources in collaborative research

Speaker(s)

Matthew  Schrag, MD, PhD

Keynote Speaker

Matthew Schrag, MD, PhD

Vanderbilt University Medical Center, United States

Assistant Professor of Neurology & Director, Cerebral Amyloid Angiopathy Clinic

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。